Specialty code 1835P2201X · Fort Worth, TX
NPI
1679027759
Since 2016
Specialty
Specialty code 1835P2201X
Code 1835P2201X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
1350 S Main St, Suite 1600
Fort Worth, TX, 76104
Phone (817) 702-3701
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$1.2M
176 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Esther Fasanmi prescribed most often to Medicare patients was Cabenuva (Cabotegravir/Rilpivirine), with 156 prescriptions and refills. In total Esther Fasanmi wrote 176 Medicare prescriptions that cost $1.2M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-08-07.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Cabenuva Cabotegravir/Rilpivirine | 156 | 269 | 33 | $991K |
Brand drugs: 169 claims; generic drugs: - claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Esther Fasanmi were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.